How to produce fluorescent nanoparticles for medical applications in a nuclear reactor
Under the leadership of Petr Cígler from the Institute of Organic Chemistry and biochemistry (IOCB Prague) and Martin Hrubý from the Institute of Macromolecular Chemistry (IMC), both of which are part of the Czech Academy of Sciences, a team of researchers has developed a revolutionary method for the easy and inexpensive production of irradiated nanodiamonds and other nanomaterials suitable for use in highly sensitive diagnostics of diseases, including various types of cancer.
The nanocrystals must first be dispersed in molten boron oxide and then subjected to neutron irradiation in a nuclear reactor.
IOCB Prague
Neutron capture by boron nuclei produces a dense shower of helium and lithium ions, which have the same effect within the nanocrystals as the ions produced in an accelerator: the controlled creation of crystal defects.
IOCB Prague
Diagnosing diseases and understanding the processes that take place within cells at the molecular level require sensitive and selective diagnostic instruments. Today, scientists can monitor magnetic and electric fields in cells at a resolution of several dozen nanometers and with remarkable sensitivity thanks to crystal defects in the particles of certain inorganic materials. A nearly ideal material for these purposes is diamond. Compared with the diamonds used in jewelry, the ones intended for applications in diagnostics and nanomedicine - nanodiamonds - are approximately a million times smaller and are produced synthetically from graphite at high pressure and temperatures.
A pure nanodiamond, though, doesn't reveal much about its environment. First, its crystal lattice must be damaged under controlled conditions to create special defects, so-called nitrogen-vacancy centers, which enable optical imaging. The damage is most commonly created by irradiating nanodiamonds with fast ions in particle accelerators. These accelerated ions are capable of knocking carbon atoms out of the crystal lattice of a nanodiamond, leaving behind holes known as vacancies, which at high temperatures then pair with nitrogen atoms present in the crystal as contaminants. The newly formed nitrogen-vacancy centers are a source of fluorescence, which can then be observed. It's precisely this fluorescence that gives nanodiamonds immense potential for applications in medicine and technology.
A fundamental restriction to the use of these materials on a broader scale, however, is the great cost and poor efficiency of irradiating ions in an accelerator, which prevents the generation of this exceptionally valuable material in larger quantities.
The team of scientists from several research centers headed by Petr Cígler and Martin Hrubý has recently described an entirely new method of irradiating nanocrystals. In place of costly and time-consuming irradiation in an accelerator, the scientists exploited irradiation in a nuclear reactor, which is much faster and far less expensive.
But it wasn't quite that simple. The scientists had to employ a trick - in the reactor, neutron irradiation splits boron atoms into very light and fast ions of helium and lithium. The nanocrystals must first be dispersed in molten boron oxide and then subjected to neutron irradiation in a nuclear reactor. Neutron capture by boron nuclei produces a dense shower of helium and lithium ions, which have the same effect within the nanocrystals as the ions produced in an accelerator: the controlled creation of crystal defects. The high density of this particle shower and the use of a reactor to irradiate a much larger quantity of material mean that it is easier and far more affordable to produce dozens of grams of rare nanomaterial at once, which is approximately one thousand times more than scientists have thus far been able to obtain through comparable irradiation in accelerators.
The method has proven successful not only in the creation of defects in the lattice of nanodiamonds but of another nanomaterial as well - silicon carbide. For this reason, scientists hypothesize that the method could find universal application in the large-scale production of nanoparticles with defined defects.
The new method utilizes the principle applied in boron neutron capture therapy (BNCT), in which patients are administered a boron compound. Once the compound has collected in the tumor, the patient receives radiation therapy with neutrons, which split the boron nuclei into ions of helium and lithium. These then destroy the tumor cells that the boron has collected in. This principle taken from experimental cancer treatment thus has opened the door to the efficient production of nanomaterials with exceptional potential for applications in, among other areas, cancer diagnostics.
Original publication
Jan Havlik, Vladimira Petrakova, Jan Kucka, Helena Raabova, Dalibor Panek, Vaclav Stepan, Zuzana Zlamalova Cilova, Philipp Reineck, Jan Stursa, Jan Kucera, Martin Hruby & Petr Cigler; "Extremely rapid isotropic irradiation of nanoparticles with ions generated in situ by a nuclear reaction"; Nature Comm.; 2018
Other news from the department science
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
DynaPro Plate Reader III by Wyatt Technology
Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)
Efficiently characterize your sample quality and stability from lead discovery to quality control
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
